p38MAPK is a novel DNA damage response‐independent regulator of the senescence‐associated secretory phenotype

A Freund, CK Patil, J Campisi - The EMBO journal, 2011 - embopress.org
A Freund, CK Patil, J Campisi
The EMBO journal, 2011embopress.org
Cellular senescence suppresses cancer by forcing potentially oncogenic cells into a
permanent cell cycle arrest. Senescent cells also secrete growth factors, proteases, and
inflammatory cytokines, termed the senescence‐associated secretory phenotype (SASP).
Much is known about pathways that regulate the senescence growth arrest, but far less is
known about pathways that regulate the SASP. We previously showed that DNA damage
response (DDR) signalling is essential, but not sufficient, for the SASP, which is restrained …
Cellular senescence suppresses cancer by forcing potentially oncogenic cells into a permanent cell cycle arrest. Senescent cells also secrete growth factors, proteases, and inflammatory cytokines, termed the senescence‐associated secretory phenotype (SASP). Much is known about pathways that regulate the senescence growth arrest, but far less is known about pathways that regulate the SASP. We previously showed that DNA damage response (DDR) signalling is essential, but not sufficient, for the SASP, which is restrained by p53. Here, we delineate another crucial SASP regulatory pathway and its relationship to the DDR and p53. We show that diverse senescence‐inducing stimuli activate the stress‐inducible kinase p38MAPK in normal human fibroblasts. p38MAPK inhibition markedly reduced the secretion of most SASP factors, constitutive p38MAPK activation was sufficient to induce an SASP, and p53 restrained p38MAPK activation. Further, p38MAPK regulated the SASP independently of the canonical DDR. Mechanistically, p38MAPK induced the SASP largely by increasing NF‐κB transcriptional activity. These findings assign p38MAPK a novel role in SASP regulation—one that is necessary, sufficient, and independent of previously described pathways.
embopress.org